Millennium Capital Advisors LLC Acquires Shares of 4,724 SPDR S&P Biotech ETF $XBI

Millennium Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 4,724 shares of the exchange traded fund’s stock, valued at approximately $576,000.

Several other institutional investors have also recently bought and sold shares of the business. AlphaCore Capital LLC raised its position in SPDR S&P Biotech ETF by 1,638.6% in the 4th quarter. AlphaCore Capital LLC now owns 7,650 shares of the exchange traded fund’s stock valued at $933,000 after purchasing an additional 7,210 shares during the last quarter. Bessemer Group Inc. raised its position in SPDR S&P Biotech ETF by 13.5% in the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after purchasing an additional 220,244 shares during the last quarter. Thrivent Financial for Lutherans raised its position in SPDR S&P Biotech ETF by 66.3% in the 4th quarter. Thrivent Financial for Lutherans now owns 137,863 shares of the exchange traded fund’s stock valued at $16,809,000 after purchasing an additional 54,966 shares during the last quarter. Cornerstone Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 1.6% in the 4th quarter. Cornerstone Wealth Management LLC now owns 7,727 shares of the exchange traded fund’s stock valued at $942,000 after purchasing an additional 123 shares during the last quarter. Finally, Pinnacle Associates Ltd. raised its position in shares of SPDR S&P Biotech ETF by 6.9% during the fourth quarter. Pinnacle Associates Ltd. now owns 11,766 shares of the exchange traded fund’s stock worth $1,435,000 after acquiring an additional 760 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 3.1%

XBI stock opened at $130.69 on Friday. The company has a market cap of $8.34 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $77.33 and a twelve month high of $139.19. The business has a fifty day moving average of $129.38 and a 200-day moving average of $124.41.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.